MedPath

Medfavour (Beijing) Medical Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Efficacy Study of NOYA Sirolimus-Eluting Stent to Treat Coronary Artery Disease

Not Applicable
Conditions
Coronary Artery Disease
Interventions
Device: NOYA CoCr Biodegradable Coating Sirolimus-Eluting Stent System
First Posted Date
2014-08-13
Last Posted Date
2014-08-13
Lead Sponsor
Medfavour (Beijing) Medical Co., Ltd
Target Recruit Count
2000
Registration Number
NCT02216058
Locations
🇨🇳

Chinese PLA General Hospital, Beijing, Beijing, China

NOYA CoCr Biodegradable Coating Sirolimus-Eluting Coronary Stent System

Not Applicable
Conditions
Coronary Artery Diseases
Interventions
Device: stent
First Posted Date
2010-10-22
Last Posted Date
2012-05-22
Lead Sponsor
Medfavour (Beijing) Medical Co., Ltd
Target Recruit Count
300
Registration Number
NCT01226355
Locations
🇨🇳

Fuwai Hospital, National Center for Cardiovascular Diseases, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath